Company intelligence / Profile preview

Huntington Study Group

Rochester, New York, United Stateshuntingtonstudygroup.org ↗

Ownership: Private
Development stage: Commercial

Overview

Pioneering global non-profit/CRO dedicated to accelerating treatments for Huntington's disease via high-quality multicenter clinical trials—including pivotal work leading to FDA approval of deutetrabenazine/AUSTEDO™—and advancing standards like UHDRS® while providing education/training resources worldwide.

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapy
Industry: Contract Research Organization

Partnerships

Teva PharmaceuticalsAcademic medical centers worldwide

Beyond the preview

Go deeper on Huntington Study Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huntington Study Group.

Explore the full profile